medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2005, Número 2

<< Anterior Siguiente >>

Rev Inst Nal Enf Resp Mex 2005; 18 (2)


Perspectivas del uso de antioxidantes como coadyuvantes en el tratamiento del asma

Olivares-Corichi IM, Guzmán-Grenfell AM, Sierra VMP, Mendoza ARS, Hicks GJJ

Idioma: Español
Referencias bibliográficas: 28
Paginas: 154-161
Archivo PDF: 82.10 Kb.


RESUMEN

Al tratarse de un proceso inflamatorio, en el asma hay participación e incremento en la generación de especies reactivas del oxígeno, dando lugar a un desequilibrio oxidante/antioxidante, fenómeno que se ha descrito como estrés oxidante, que causa daño a diferentes biomoléculas. La utilización de agentes antioxidantes exógenos o activadores de antioxidantes endógenos como coadyuvantes de la terapéutica del paciente asmático, es una posibilidad a discutir.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. McNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195-207.

  2. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflamation. Eur Respir J 2000;16:534-554.

  3. Misso NLM, Powers KA, Gillon RL. Reduced platelet gluthatione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clin Exp Allergy 1996;26:838-847.

  4. Sierra VMP, Olivares-Corichi IM, Torres RYD, et al. Participación de los fosfolípidos plasmáticos como sustratos predisponentes al estrés oxidante. XLIV Congreso Internacional de Endocrinología. Memorias (138). Diciembre, 2004. Acapulco, Guerrero. México.

  5. Robinson C, Holgate ST. Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. Clin Sci 1985;68:103-112.

  6. Salmon JA. Measurement of eicosanoids by bioassay and radioimmunoassay. Br Med Bul 1983;39:227-235.

  7. Nadeen A, Chhabra SK, Masood A, Raj HG. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003;111:72-78.

  8. Blesa S, Cortijo J, Mata M, et al. Oral N cysteine attenuates the rat pulmonary inflammatory response to antigen. Eur Respir J 2003;21:394-400.

  9. Hicks JJ, Silva-Gomez, Vilar-Rojas C. Induction of antioxidant enzymes by dexametasone in the adult rat lung. Life Sci 1997; 60: 2059-2067.

  10. Macmillan-Crow LA, Cruthirds DL. Invited review: manganese superoxide dismutase in disease. Free Radic Res 2001;34:325-336.

  11. Delbosc S, Cristol JP, Descomps B, Chenard J, Sirois P. Oxygen and the superoxide anion. Modulation of NADPH oxidase? J Soc Biol 2001;195:401-411.

  12. Ko SH, Choi SW, Ye SK, Cho BL, Kim HS, Chung MH. Comparison of the antioxidant activities of nine different fruits in human plasma. J Med Food 2005; 8:41-46.

  13. Romiu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001;23:268-287.

  14. Olivares-Corichi IM, Medina-Santillan R, Fernandez del Valle-Laisequilla C, Alvarez P, Hicks JJ. Increase of plasma antioxidant capacity with a novel formulation of antioxidants. Proc West Pharmacol Soc 2003;46:45-47.

  15. Kelly FJ. Dietary antioxidants and environmental stress. Proc Nutr Soc 2004; 63:579-585.

  16. Baker JC, Tunnicliffe WS, Duncanson RC. Dietary antioxidants and magnesium in type I brittle asthma: a case control study. Throrax 1999;54:115-118.

  17. Omenaas E, Fluge O, Buist AS, Vollmer WM, Gulsvik A. Dietary vitamin C intake is inversely related to cough and wheeze in young smokers. Respir Med 2003; 97:132-142.

  18. Lara-Padilla E, Osorio-Victoria ML. Nutrición humana. En: Hicks JJ, editor. Bioquímica. México, DF: McGraw-Hill Interamericana; 2002.p.793-834.

  19. May JM, Qu ZC, Whitesell RR, Cobb CE. Ascorbate recycling in human erythrocytes: Role of GSH in reducing dehydroascorbate. Free Rad Biol Med 1996;20:543-547.

  20. Constantinescu A, Han D, Packer L. Vitamin E recycling in human erythrocyte membranes. J Biol Chem 1993;268:106-109.

  21. Reiter RJ, Tan DX, Qi W, Manchester LC, Karbownik M, Calvo JR. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 2000;9:160-171.

  22. Beyer CE, Steketee JD, Saphier D. Antioxidant properties of melatoninan emerging mystery. Biochem Pharmacol 1998;56:1265-1272.

  23. Medina-Navarro R, Duran-Reyes G, Hicks JJ. Pro-oxidating properties of melatonin in the in vitro interaction with the singlet oxygen. Endocrine Res 1999;25:263-280.

  24. Lena PJ, Subramanian P. Effects of melatonin on the levels of antioxidants and lipid peroxidation products in rats treated with ammonium acetate. Pharmazie 2004;59:636-639.

  25. Onuki J, Almeida EA, Medeiros MH, Di Mascio P. Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005;38:107-115.

  26. Yin D. Is carbonyl detoxification an important anti-aging process during sleep? Med Hypotheses 2000;54:19-22.

  27. Liu CS, Wei YH. Age-associated alteration of blood thiol-group-related antioxidants in smokers. Environ Res 1999;80:18-24.

  28. Regelson W, Loria R, Kalimi M. Hormonal intervention: “buffer hormones” or “state dependency”. The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging. Ann N Y Acad Sci 1988;521:260-273.




2020     |     www.medigraphic.com